Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Metlife (MET)
NYSE:MET
Holding MET?
Track your performance easily
See the Price Targets and Ratings of:
MET Analyst Ratings
Strong Buy
9 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MET Stock 12 Month Forecast
Average Price Target
$86.20
▲(8.77% Upside)
| Highest Price Target$96.00 | Average Price Target$86.20 | Lowest Price Target$81.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
Initiated
09/05/24
Morgan Stanley
Reiterated
08/19/24
Deutsche Bank
Reiterated
08/19/24
Wells Fargo
Assigned
08/12/24
Jefferies
Assigned
08/04/24
Bank of America Securities
Assigned
08/01/24
Citi
Reiterated
07/23/24
J.P. Morgan
Reiterated
07/02/24
Piper Sandler
Assigned
06/28/24
Argus Research
$77→$80
Buy
0.95%
Upside
Reiterated
05/22/24
MetLife price target raised to $80 from $77 at ArgusMetLife price target raised to $80 from $77 at Argus
CFRA
$70→$77
Hold
-2.84%
Downside
Reiterated
03/13/24
MetLife (MET) PT Raised to $77 at CFRACFRA analyst Catherine Seifert raised the price target on MetLife (NYSE: MET) to $77.00 (from $70.00) while maintaining a Hold rating.
UBS
$87→$82
Buy
3.47%
Upside
Reiterated
02/05/24
MetLife (MET) PT Lowered to $82 at UBSUBS analyst Brian Meredith lowered the price target on MetLife (NYSE: MET) to $82.00 (from $87.00) while maintaining a Buy rating.
Evercore ISI
$84→$83
Buy
4.73%
Upside
Reiterated
02/01/24
MetLife (MET) PT Lowered to $83 at Evercore ISIEvercore ISI analyst Thomas Gallagher lowered the price target on MetLife (NYSE: MET) to $83.00 (from $84.00) while maintaining a Outperform rating.
Unknown Analyst
Not Ranked
Autonomous Research
$84
Buy
5.99%
Upside
Initiated
04/09/24
Autonomous Research starts MetLife (MET) at OutperformAutonomous Research initiates coverage on MetLife (NYSE: MET) with a Outperform rating and a price target of $84.00.
Best Analysts Covering Metlife
Which Analyst Should I Follow If I Want to Buy MET and Sell After:
1 Month
xxx
Success Rate
16/24 ratings generated profit
Average Return
+3.18%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +3.18% per trade.
3 Months
xxx
Success Rate
18/27 ratings generated profit
Average Return
+4.99%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +4.99% per trade.
1 Year
Success Rate
22/24 ratings generated profit
Average Return
+19.03%
assigned a buy rating 2 months ago
Copying Ryan Krueger's trades and holding each position for 1 Year would result in 91.67% of your transactions generating a profit, with an average return of +19.03% per trade.
2 Years
xxx
Success Rate
27/28 ratings generated profit
Average Return
+23.21%
assigned a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 96.43% of your transactions generating a profit, with an average return of +23.21% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MET Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Sep 24
Strong Buy
0
0
0
0
0
Buy
15
17
15
13
12
Hold
1
0
1
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
17
16
15
14
Each month's total comprises the sum of three months' worth of ratings.
MET Financial Forecast
MET Stock Forecast FAQ
What is MET’s average 12-month price target, according to analysts?
Based on analyst ratings, Metlife’s 12-month average price target is $86.20.
What is MET’s upside potential, based on the analysts’ average price target?
Metlife has 8.77% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MET a Buy, Sell or Hold?
Metlife has a consensus rating of Strong Buy which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.
What is Metlife’s price target?
The average price target for Metlife is $86.20. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $96.00 ,the lowest forecast is $81.00. The average price target represents 8.77% Increase from the current price of $79.25.
The highest analyst price target is $96.00 ,the lowest forecast is $81.00. The average price target represents 8.77% Increase from the current price of $79.25.
What do analysts say about Metlife?
Metlife’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of MET?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.